enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Category:Drugs developed by Novartis - Wikipedia

    en.wikipedia.org/wiki/Category:Drugs_developed...

    Pages in category "Drugs developed by Novartis" The following 135 pages are in this category, out of 135 total. This list may not reflect recent changes. A.

  3. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    In 2013, the Indian Supreme Court issued a decision rejecting Novartis' patent application in India on the final form of Gleevec, Novartis's cancer drug; the case caused great controversy. [45] In 2013, Novartis was sued again by the US government, this time for allegedly bribing doctors for a decade so that their patients are steered towards ...

  4. List of patent medicines - Wikipedia

    en.wikipedia.org/wiki/List_of_patent_medicines

    E. W. Kemble's "Death's Laboratory" on the cover of Collier's (June 3, 1905). A patent medicine, also known as a proprietary medicine or a nostrum (from the Latin nostrum remedium, or "our remedy") is a commercial product advertised to consumers as an over-the-counter medicine, generally for a variety of ailments, without regard to its actual effectiveness or the potential for harmful side ...

  5. The 10 Biggest-Selling Drugs That Are About to Lose Their Patent

    www.aol.com/news/2011-02-27-top-selling-drugs...

    Plavix. This anti-clot or blood thinner most prescribed to prevent heart attack or stroke claims the title of second-best selling drug in the world, with $9.4 billion in global sales in 2010.

  6. Novartis loses initial bid to block generic of best-selling ...

    www.aol.com/news/novartis-loses-initial-bid...

    MSN's version of Entresto was approved by the U.S. Food and Drug Administration last month and would be the first U.S. generic of the drug. Novartis said in a statmement that it was "considering ...

  7. FDA Approves Expanded Use Of Novartis' Rare Disease Drug ...

    www.aol.com/finance/fda-approves-expanded...

    On Thursday, the FDA granted accelerated approval to Novartis AG’s (NYSE:NVS) Fabhalta (iptacopan), a first-in-class complement inhibitor for the reduction of proteinuria in adults with primary ...

  8. Chiron Corporation - Wikipedia

    en.wikipedia.org/wiki/Chiron_Corporation

    Chiron was the first to clone HCV in 1989 after six years of research [8] and had since filed over 100 HCV related patents in over 20 countries. [31] A settlement was reached where Roche Holding A.G. agreed to buy the global semi-exclusive nucleic acid test (NAT) patents for HCV and HIV from Chiron. [25]

  9. Novartis' Plans to Protect Sandostatin's Billion-Dollar Franchise

    www.aol.com/2013/11/12/novartis-plans-to-protect...

    Novartis has been These teams are spending big money bulking up pipelines with specialty drugs designed to replace prior generation therapies. Novartis' Plans to Protect Sandostatin's Billion ...